These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35981371)
1. [Analysis of Clinical Characteristics and Prognostic Factors of Patients with Limited-Stage Mantle Cell Lymphoma]. Sun J; He S; Rong C; Cen H; Tan XH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1123-1128. PubMed ID: 35981371 [TBL] [Abstract][Full Text] [Related]
2. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China. He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy and Prognosis of Chemotherapy Regimen Containing BTK Inhibitor in Treatment of Recurrent/Refractory Mantle Cell Lymphoma]. Chen H; Liu XY; Chang Y; Chen ZQ; Li WQ; Zhang L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):125-131. PubMed ID: 38387910 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report. Jo JC; Kim SJ; Lee HS; Eom HS; Lee SI; Park Y; Lee JO; Lee Y; Yhim HY; Yang DH; Byun JM; Kang HJ; Kim HJ; Shin HJ; Yoo KH; Suh C; Ann Hematol; 2020 Feb; 99(2):223-228. PubMed ID: 31853704 [TBL] [Abstract][Full Text] [Related]
6. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Greenwell IB; Staton AD; Lee MJ; Switchenko JM; Saxe DF; Maly JJ; Blum KA; Grover NS; Mathews SP; Gordon MJ; Danilov AV; Epperla N; Fenske TS; Hamadani M; Park SI; Flowers CR; Cohen JB Cancer; 2018 Jun; 124(11):2306-2315. PubMed ID: 29579328 [TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of the character and prognostic factors of 23 cases of mantle cell lymphoma]. Liang R; Wang Z; Zhu MN; Hao CX; Zhang N; Wang JH; Zhang T; Yang L; Gu HT; Dong BX; Bai QX; Gao GX; Chen XQ Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):491-6. PubMed ID: 27431074 [TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database. Salek D; Vesela P; Boudova L; Janikova A; Klener P; Vokurka S; Jankovska M; Pytlik R; Belada D; Pirnos J; Moulis M; Kodet R; Michal M; Janousova E; Muzik J; Mayer J; Trněný M Leuk Lymphoma; 2014 Apr; 55(4):802-10. PubMed ID: 23772666 [TBL] [Abstract][Full Text] [Related]
9. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837 [TBL] [Abstract][Full Text] [Related]
10. [Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients]. Campbell J; Hurtado S; Kutz C; Soto K; Ernst D Rev Med Chil; 2019; 147(1):9-17. PubMed ID: 30848759 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 140 cases of mantle cell lymphoma]. Hu MW; Lou YJ; Yang M; Wang HF; Wang L; Jin J Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):390-395. PubMed ID: 29860768 [No Abstract] [Full Text] [Related]
12. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission. Chakhachiro ZI; Saliba RM; Okoroji GJ; Korbling M; Alousi AM; Betul O; Anderlini P; Ciurea SO; Popat U; Champlin R; Samuels BI; Medeiros LJ; Bueso-Ramos C; Khouri IF Cancer; 2013 Sep; 119(18):3318-25. PubMed ID: 23775587 [TBL] [Abstract][Full Text] [Related]
13. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573 [TBL] [Abstract][Full Text] [Related]
14. Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population. Yang X; Khoo LP; Chang EWY; Yang VS; Poon E; Somasundaram N; Farid M; Tang TPL; Tao M; Lim ST; Chan JY BMC Cancer; 2021 May; 21(1):566. PubMed ID: 34001056 [TBL] [Abstract][Full Text] [Related]
15. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma]. Zhang HX; Xu J; Liu T; Xu CG Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704 [TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091 [TBL] [Abstract][Full Text] [Related]
17. [Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era]. Xu CB; Hu M; Shen JZ; Xu HQ; Zheng RJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):722-729. PubMed ID: 37356932 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Body Mass Index on the Prognosis of Mantle Cell Lymphoma]. Zhang SX; Xie YH; Weng P; Xu SJ; Tian HY; Guo JR; Liu TB; Shen JZ; Li XF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1757-1765. PubMed ID: 36476900 [TBL] [Abstract][Full Text] [Related]
19. Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis. Yang P; Cai QQ; Zhang W; Liu SZ; Liu H; Sun XH; Dong YJ; Xiao XB; Wang JW; Li ZL; Huang WR; Li LH; Bao HZ; Yang W; Wang YL; Wang SY; He J; Li XL; Liu AC; Jing HM Cancer Med; 2023 Jun; 12(12):13204-13216. PubMed ID: 37148540 [TBL] [Abstract][Full Text] [Related]
20. [Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas]. Wu Y; Wang H; Liu XJ; Wang YY; Zhao WL; Li JM; Shen ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1036-1041. PubMed ID: 28823264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]